HIVE Blockchain Technologies (CVE:HIV – Get Free Report) was upgraded by equities research analysts at Roth Capital to a “strong-buy” rating in a research report issued on Wednesday,Zacks.com reports.
A number of other research firms have also recently issued reports on HIV. Cantor Fitzgerald upgraded shares of HIVE Blockchain Technologies to a “strong-buy” rating in a research report on Tuesday, October 29th. Northland Capmk upgraded shares of HIVE Blockchain Technologies to a “strong-buy” rating in a report on Thursday, September 19th.
View Our Latest Research Report on HIVE Blockchain Technologies
HIVE Blockchain Technologies Price Performance
Read More
- Five stocks we like better than HIVE Blockchain Technologies
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Why Wall Street Sees Major Upside for PayPal Stock
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Cintas Shares Slide: A Prime Opportunity to Buy the Dip
- Want to Profit on the Downtrend? Downtrends, Explained.
- Tempus AI: A Potential Double-Bagger After Recent Pullback
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
